Literature DB >> 32069128

Audiological outcome measures with the BONEBRIDGE transcutaneous bone conduction hearing implant: impact of noise, reverberation and signal processing features.

Ioan A Curca1,2, Vijay Parsa1,2, Ewan A Macpherson1,2, Susan Scollie1,2, Katherine Vansevenant3, Kim Zimmerman3, Jamie Lewis-Teeter3, Prudence Allen1,2, Lorne Parnes3,4, Sumit Agrawal3,4.   

Abstract

Objective: To assess the performance of an active transcutaneous implantable-bone conduction device (TI-BCD), and to evaluate the benefit of device digital signal processing (DSP) features in challenging listening environments.Design: Participants were tested at 1- and 3-month post-activation of the TI-BCD. At each session, aided and unaided phoneme perception was assessed using the Ling-6 test. Speech reception thresholds (SRTs) and quality ratings of speech and music samples were collected in noisy and reverberant environments, with and without the DSP features. Self-assessment of the device performance was obtained using the Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire.Study sample: Six adults with conductive or mixed hearing loss.
Results: Average SRTs were 2.9 and 12.3 dB in low and high reverberation environments, respectively, which improved to -1.7 and 8.7 dB, respectively with the DSP features. In addition, speech quality ratings improved by 23 points with the DSP features when averaged across all environmental conditions. Improvement scores on APHAB scales revealed a statistically significant aided benefit.Conclusions: Noise and reverberation significantly impacted speech recognition performance and perceived sound quality. DSP features (directional microphone processing and adaptive noise reduction) significantly enhanced subjects' performance in these challenging listening environments.

Entities:  

Keywords:  APHAB; BONEBRIDGE; Bone-anchored hearing aid; directional microphone; noise reduction; reverberation; sound quality; speech intelligibility

Mesh:

Year:  2020        PMID: 32069128     DOI: 10.1080/14992027.2020.1728400

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  3 in total

1.  Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.

Authors:  Bartłomiej Król; Katarzyna Beata Cywka; Magdalena Beata Skarżyńska; Piotr Henryk Skarżyński
Journal:  Life (Basel)       Date:  2021-04-22

2.  Effect of transducer placements on thresholds in ears with an abnormal ear canal and severe conductive hearing loss.

Authors:  Tadashi Nishimura; Hiroshi Hosoi; Osamu Saito; Ryota Shimokura; Chihiro Morimoto; Tadao Okayasu; Tadashi Kitahara
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-10

3.  Self-Rated Benefits of Auditory Performance after Bonebridge Implantation in Patients with Conductive or Mixed Hearing Loss, or Single-Sided Deafness.

Authors:  Anna Ratuszniak; Piotr H Skarzynski; Elżbieta Gos; Henryk Skarzynski
Journal:  Life (Basel)       Date:  2022-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.